A detailed history of Raymond James & Associates transactions in Stryker Corp stock. As of the latest transaction made, Raymond James & Associates holds 724,533 shares of SYK stock, worth $264 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
724,533
Previous 586,617 23.51%
Holding current value
$264 Million
Previous $200 Million 31.12%
% of portfolio
0.16%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$315.94 - $371.96 $43.6 Million - $51.3 Million
137,916 Added 23.51%
724,533 $262 Million
Q2 2024

Jul 19, 2024

SELL
$324.3 - $354.67 $1.49 Million - $1.63 Million
-4,599 Reduced 0.78%
586,617 $200 Million
Q1 2024

Apr 22, 2024

BUY
$293.94 - $358.71 $7.26 Million - $8.86 Million
24,689 Added 4.36%
591,216 $212 Million
Q4 2023

Jan 16, 2024

BUY
$253.85 - $299.46 $840,243 - $991,212
3,310 Added 0.59%
566,527 $170 Million
Q3 2023

Oct 24, 2023

BUY
$266.54 - $302.43 $2.4 Million - $2.72 Million
9,005 Added 1.62%
563,217 $154 Million
Q2 2023

Jul 25, 2023

SELL
$271.49 - $305.09 $6.91 Million - $7.77 Million
-25,466 Reduced 4.39%
554,212 $169 Million
Q1 2023

Apr 14, 2023

BUY
$246.13 - $285.47 $8.69 Million - $10.1 Million
35,299 Added 6.48%
579,678 $165 Million
Q4 2022

Feb 08, 2023

BUY
$205.51 - $253.93 $4.2 Million - $5.19 Million
20,440 Added 3.9%
544,379 $133 Million
Q3 2022

Oct 25, 2022

BUY
$189.27 - $231.83 $13 Million - $15.9 Million
68,452 Added 15.03%
523,939 $106 Million
Q2 2022

Aug 12, 2022

BUY
$194.09 - $276.37 $9.3 Million - $13.2 Million
47,904 Added 11.75%
455,487 $90.6 Million
Q1 2022

May 11, 2022

BUY
$245.33 - $277.77 $2.05 Million - $2.33 Million
8,373 Added 2.1%
407,583 $109 Million
Q4 2021

Feb 08, 2022

BUY
$236.63 - $276.44 $404,873 - $472,988
1,711 Added 0.43%
399,210 $107 Million
Q3 2021

Nov 02, 2021

SELL
$248.9 - $280.09 $1.64 Million - $1.85 Million
-6,602 Reduced 1.63%
397,499 $105 Million
Q2 2021

Aug 11, 2021

BUY
$242.95 - $267.0 $2.57 Million - $2.82 Million
10,560 Added 2.68%
404,101 $105 Million
Q1 2021

May 14, 2021

SELL
$221.01 - $248.82 $4.61 Million - $5.19 Million
-20,875 Reduced 5.04%
393,541 $95.9 Million
Q4 2020

Feb 12, 2021

BUY
$202.01 - $245.04 $5.51 Million - $6.68 Million
27,271 Added 7.04%
414,416 $102 Million
Q3 2020

Nov 04, 2020

BUY
$177.77 - $215.81 $2.73 Million - $3.32 Million
15,370 Added 4.13%
387,145 $80.7 Million
Q2 2020

Jul 28, 2020

BUY
$144.67 - $207.03 $3.51 Million - $5.02 Million
24,267 Added 6.98%
371,775 $67 Million
Q1 2020

Apr 21, 2020

BUY
$126.5 - $225.1 $681,455 - $1.21 Million
5,387 Added 1.57%
347,508 $57.9 Million
Q4 2019

Feb 12, 2020

BUY
$197.98 - $220.53 $4.67 Million - $5.2 Million
23,591 Added 7.41%
342,121 $71.8 Million
Q3 2019

Nov 07, 2019

BUY
$205.4 - $221.82 $2.24 Million - $2.42 Million
10,926 Added 3.55%
318,530 $68.9 Million
Q2 2019

Aug 06, 2019

BUY
$180.24 - $205.58 $2 Million - $2.28 Million
11,093 Added 3.74%
307,604 $63.2 Million
Q1 2019

May 06, 2019

BUY
$152.46 - $198.0 $10.7 Million - $13.9 Million
70,048 Added 30.93%
296,511 $58.6 Million
Q4 2018

Feb 11, 2019

BUY
$145.0 - $178.65 $630,025 - $776,234
4,345 Added 1.96%
226,463 $35.5 Million
Q3 2018

Nov 14, 2018

BUY
$163.25 - $177.68 $2.22 Million - $2.42 Million
13,621 Added 6.53%
222,118 $39.5 Million
Q2 2018

Aug 14, 2018

BUY
$155.17 - $179.78 $4.96 Million - $5.74 Million
31,946 Added 18.09%
208,497 $35.2 Million
Q1 2018

May 14, 2018

BUY
$148.01 - $168.91 $2.17 Million - $2.48 Million
14,690 Added 9.08%
176,551 $28.4 Million
Q4 2017

Feb 14, 2018

BUY
$143.51 - $159.74 $1.06 Million - $1.18 Million
7,399 Added 4.79%
161,861 $25.1 Million
Q3 2017

Nov 13, 2017

BUY
$138.36 - $147.87 $534,207 - $570,926
3,861 Added 2.56%
154,462 $21.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
150,601
150,601 $20.9 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.